Oppenheimer analyst Akiva Felt maintained an Outperform rating on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), as a webpage from Johns Hopkins School of Public Health states that …
Oppenheimer analyst Akiva Felt reiterated an Outperform rating on Dyax Corp (NASDAQ:DYAX) and slightly raised his price target to $14 (from $13). Felt noted, …
In a research report issued Tuesday, Oppenheimer analyst Akiva Felt maintained an Outperform rating on Zogenix (NASDAQ:ZGNX) with a price target of $2.50, …
In a research report issued today, Oppenheimer analyst Akiva Felt reiterated an Outperform rating on Cubist Pharmaceuticals (NASDAQ:CBST) with a price target of …
In a research report issued today, Oppenheimer analyst Akiva Felt initiated coverage with an Outperform rating on Foamix Pharmaceuticals (NASDAQ:FOMX) and a $15 price target, which represents …
In a research note published today, Oppenheimer analyst Akiva Felt maintained an Outperform rating on Zogenix (NASDAQ:ZGNX) with a $2.50 price target, as the …
